Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 612 entries
Sorted by: Best Match Show Resources per page
Lynch Syndrome Associated Colon Adenocarcinoma Resembling Lymphoma on Fluoro-Deoxyglucose-Positron Emission Tomography/Computed Tomography.

World journal of nuclear medicine

Aparici CM, Win AZ.
PMID: 26420998
World J Nucl Med. 2015 Sep-Dec;14(3):222-4. doi: 10.4103/1450-1147.161728.

The patient was a 46-year-old Asian male diagnosed with lynch syndrome associated colon adenocarcinoma in the right ascending colon. A presurgical staging 18-fluoro-deoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) found increased metabolic activity in the cervical, axillary, mediastinal, supraclavicular, para-aortic and...

Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report.

Oncology letters

Iovino F, Orditura M, Auriemma PP, Ciorra FR, Giordano G, Orabona C, Bara F, Sergio R, Savastano B, Fabozzi A, Laterza MM, Ventriglia J, Petrillo A, Della Corte CM, DE Vita F.
PMID: 25663920
Oncol Lett. 2015 Mar;9(3):1403-1405. doi: 10.3892/ol.2014.2822. Epub 2014 Dec 23.

Bone metastasis is an uncommon event in advanced gastric cancer patients and bone metastases are rarely detected as isolated lesions. However, eleven years after treatment for locally advanced gastric cancer, including total gastrectomy followed by adjuvant chemotherapy, a 49-year-old...

Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate.

Hospital pharmacy

Kintzel PE, VanDyke TH, Athmann PW, Mills LB, Bonter MP, Bremer MW, Dougherty ML, Foster RW, Knight SK, Slot MG, Steinmetz-Malato LL.
PMID: 25673893
Hosp Pharm. 2014 Dec;49(11):1039-43. doi: 10.1310/hjp4911-1039.

PURPOSE: To determine whether a process change impacted the proportion of orders for single-agent, high-dose methotrexate entered by chemotherapy pharmacists instead of general pharmacy staff. Coordination of antiemetic premedication and leucovorin rescue with the new method of order entry...

Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test.

Oncology letters

Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, Naito S, Sato T, Kishine K, Abe Y, Hara C, Yamada S, Mashiko S, Nagaoka I.
PMID: 29113244
Oncol Lett. 2017 Nov;14(5):6045-6052. doi: 10.3892/ol.2017.6960. Epub 2017 Sep 15.

Leucovorin (FOL) and fluorouracil (5-FU) plus oxaliplatin (l-OHP; FOLFOX) or FOL and 5-FU plus irinotecan (SN-38; FOLFIRI) are widely used as first-line chemotherapy regimens in the treatment of advanced colorectal cancer (CRC). However, second-line chemotherapy must be abandoned in...

Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer.

Case reports in oncology

Hashimoto A, Takada K, Horiguchi H, Sato T, Iyama S, Murase K, Kamihara Y, Ono K, Tatekoshi A, Hayashi T, Miyanishi K, Sato Y, Furuhata T, Kobune M, Takimoto R, Hirata K, Kato J.
PMID: 24932174
Case Rep Oncol. 2014 May 17;7(2):316-22. doi: 10.1159/000363100. eCollection 2014 May.

Therapy-related leukemia (TRL) has been reported to occur after treatment with alkylating agents and/or topoisomerase II inhibitors. Oxaliplatin (OXP) is used as a key drug for the treatment of colorectal cancer (CRC). Cisplatin and carboplatin have been linked with...

Chemotherapy for liver metastasis originating from colorectal cancer with portal vein tumor thrombosis: a case report.

Case reports in oncology

Kawasaki A, Mimatsu K, Oida T, Kano H, Kuboi Y, Fukino N, Kida K, Amano S.
PMID: 23741223
Case Rep Oncol. 2013 May 18;6(2):275-9. doi: 10.1159/000343680. Print 2013 May.

The patient was a male in his 70s with a history of chronic renal failure and dilated cardiomyopathy. In January 2011, he underwent abdominoperineal resection of the rectum, right hepatic lobectomy, and resection of a portal vein tumor thrombus...

Combination Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5-Fluorouracil-Pretreated Patients with Metastatic Colorectal Cancer.

Cancer research and treatment

Bang SM, Cho EK, Oh JH, Chang HM, Ahn JS, Lee JA, Park YI, Ahn MJ, Park YS, Shin DB, Lee JH.
PMID: 26680816
Cancer Res Treat. 2001 Oct;33(5):414-9. doi: 10.4143/crt.2001.33.5.414.

PURPOSE: To evaluate the efficacy and toxicity of oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer who previously treated with 5-FU-based chemotherapy.MATERIALS AND METHODS: Between April 1999 and January 2001, thirty-two patients...

Irinotecan Combined with Bolus Fluorouracil, Continuous Infusion Fluorouracil, and Low-Dose Leucovorin Every Two Weeks in Patients with Oxaliplatin Pretreated Metastatic Colorectal Cancer.

Cancer research and treatment

Kwon HC, Kim SH, Kim JS, Kim HJ.
PMID: 26680927
Cancer Res Treat. 2003 Apr;35(2):135-40. doi: 10.4143/crt.2003.35.2.135.

PURPOSE: To determine the efficacy and tolerance of irinotecan in combination with fluorouracil (5-FU) plus leucovorin (LV) in patients whose disease has progressed after treatment with an oxaliplatin-based therapy.MATERIALS AND METHODS: Thirty-two patients were enrolled in this study from...

Tumor lysis syndrome in a patient with metastatic colon cancer after treatment with 5-fluorouracil/leucovorin and oxaliplatin: case report and literature review.

Cancer research and treatment

Kim HD, Ha KS, Woo IS, Jung YH, Han CW, Kim TJ.
PMID: 24851114
Cancer Res Treat. 2014 Apr;46(2):204-7. doi: 10.4143/crt.2014.46.2.204. Epub 2014 Apr 22.

Development of tumor lysis syndrome (TLS) may occur after chemotherapy or spontaneously in bulky or rapidly growing tumors. This syndrome is frequent but preventable in patients with hematologic malignancies. TLS following therapy has been reported infrequently in various types...

Laparoscopic diagnosis of adenocarcinoma of the appendix mimicking serous papillary adenocarcinoma of the peritoneum.

Case reports in obstetrics and gynecology

Yoshimura M, Terai Y, Konishi H, Tanaka Y, Tanaka T, Sasaki H, Ohmichi M.
PMID: 24383020
Case Rep Obstet Gynecol. 2013;2013:248917. doi: 10.1155/2013/248917. Epub 2013 Dec 09.

Primary carcinoma of the vermiform appendix is a rare disease with few clinical symptoms. Accordingly, preoperative diagnosis of appendiceal cancer is challenging because of the lack of specific symptoms. We herein report a case of appendicular adenocarcinoma found unexpectedly...

Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.

Dermatology and therapy

Weidmann A, Foulkes AC, Kirkham N, Reynolds NJ.
PMID: 24942326
Dermatol Ther (Heidelb). 2014 Dec;4(2):145-56. doi: 10.1007/s13555-014-0056-z. Epub 2014 Jun 19.

Methotrexate continues to be one of the most widely used systemic immunosuppressive agents in dermatology. In addition to the important, well-characterized adverse effects such as hepatotoxicity and myelosuppression, methotrexate may induce a number of rare cutaneous adverse events including...

Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study.

Contemporary oncology (Poznan, Poland)

Bayoglu İV, Yildiz I, Varol U, Cokmert S, Alacacıoğlu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Tarhan O.
PMID: 26793023
Contemp Oncol (Pozn). 2015;19(5):385-90. doi: 10.5114/wo.2015.53374. Epub 2015 Aug 13.

AIM OF THE STUDY: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.MATERIAL AND METHODS: This study was a retrospective...

Showing 1 to 12 of 612 entries